Viktor Posse

Viktor Posse

Auto-generated profile, based on publicly available information

Viktor Posse

Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CKChristian Kukat
Christian Kukat
KDKaren M. Davies
Karen M. Davies
CWChristian A. Wurm
Christian A. Wurm
HSHenrik Spåhr
Henrik Spåhr
NBNina A. Bonekamp
Nina A. Bonekamp
NLNils-Göran Larsson
Nils-Göran Larsson
Significance: Altered expression of mitochondrial DNA (mtDNA) is heavily implicated in human disease and aging, but the basic organizational unit of mtDNA, the mitochondrial nucleoid, is poorly understood. Here, we have used a combination of biochemistry, superresolution microscopy, and electron microscopy to show that mammalian mitochondrial nucleoids have an irregular ellipsoidal shape and typically contain a single copy of mtDNA. Furthermore, we show that the nucleoid ultrastructure is independent of cellular mtDNA copy number and that the core nucleoid structure is formed by cross-strand binding of mitochondrial transcription factor A (TFAM) to a single copy of mtDNA. The clarification of the ultrastructure of the mammalian mitochondrial nucleoid provides the fundamental basis for the understanding of regulation of mtDNA maintenance and expression in mammals.

5 August 2016 in Science Advances
Verified
Journal Article
Open access
PDF file
IKInge Kühl
Inge Kühl
MMMaria Miranda
Maria Miranda
VPViktor Posse
Viktor Posse
DMDusanka Milenkovic
Dusanka Milenkovic
AMArnaud Mourier
Arnaud Mourier
NLNils-Göran Larsson
Nils-Göran Larsson
Mitochondria are vital in providing cellular energy via their oxidative phosphorylation system, which requires the coordinated expression of genes encoded by both the nuclear and mitochondrial genomes (mtDNA). Transcription of the circular mammalian mtDNA depends on a single mitochondrial RNA polymerase (POLRMT). Although the transcription initiation process is well understood, it is debated whether POLRMT also serves as the primase for the initiation of mtDNA replication. In the nucleus, the RNA polymerases needed for gene expression have no such role. Conditional knockout of Polrmt in the heart results in severe mitochondrial dysfunction causing dilated cardiomyopathy in young mice. We further studied the molecular consequences of different expression levels of POLRMT and found that POLRMT is essential for primer synthesis to initiate mtDNA replication in vivo. Furthermore, transcription initiation for primer formation has priority over gene expression. Surprisingly, mitochondrial transcription factor A (TFAM) exists in an mtDNA-free pool in the Polrmt knockout mice. TFAM levels remain unchanged despite strong mtDNA depletion, and TFAM is thus protected from degradation of the AAA+ Lon protease in the absence of POLRMT. Last, we report that mitochondrial transcription elongation factor may compensate for a partial depletion of POLRMT in heterozygous Polrmt knockout mice, indicating a direct regulatory role of this factor in transcription. In conclusion, we present in vivo evidence that POLRMT has a key regulatory role in the replication of mammalian mtDNA and is part of a transcriptional mechanism that provides a switch between primer formation for mtDNA replication and mitochondrial gene expression.

17 February 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
VPViktor Posse
Viktor Posse
SSSaba Shahzad
Saba Shahzad
MFMaria Falkenberg
Maria Falkenberg
BHB. Martin Hällberg
B. Martin Hällberg
CGClaes M. Gustafsson
Claes M. Gustafsson
A single-subunit RNA polymerase, POLRMT, transcribes the mitochondrial genome in human cells. Recently, a factor termed as the mitochondrial transcription elongation factor, TEFM, was shown to stimulate transcription elongation in vivo, but its effect in vitro was relatively modest. In the current work, we have isolated active TEFM in recombinant form and used a reconstituted in vitro transcription system to characterize its activities. We show that TEFM strongly promotes POLRMT processivity as it dramatically stimulates the formation of longer transcripts. TEFM also abolishes premature transcription termination at conserved sequence block II, an event that has been linked to primer formation during initiation of mtDNA synthesis. We show that POLRMT pauses at a wide range of sites in a given DNA sequence. In the absence of TEFM, this leads to termination; however, the presence of TEFM abolishes this effect and aids POLRMT in continuation of transcription. Further, we show that TEFM substantially increases the POLRMT affinity to an elongation-like DNA:RNA template. In combination with previously published in vivo observations, our data establish TEFM as an essential component of the mitochondrial transcription machinery.

29 April 2019 in EMBO Reports
Verified
Journal Article
Open access
PDF file
SJShan Jiang
Shan Jiang
CKCamilla Koolmeister
Camilla Koolmeister
JMJelena Misic
Jelena Misic
SSStefan Siira
Stefan Siira
IKInge Kühl
Inge Kühl
NLNils‐Göran Larsson
Nils‐Göran Larsson
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

3 January 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
VPViktor Posse
Viktor Posse
AAAli Al-Behadili
Ali Al-Behadili
JUJay P Uhler
Jay P Uhler
ACAnders Ranegaard Clausen
Anders Ranegaard Clausen
ARAurelio Reyes
Aurelio Reyes
CGClaes M Gustafsson
Claes M Gustafsson
Human mitochondrial DNA (mtDNA) replication is first initiated at the origin of H-strand replication. The initiation depends on RNA primers generated by transcription from an upstream promoter (LSP). Here we reconstitute this process in vitro using purified transcription and replication factors. The majority of all transcription events from LSP are prematurely terminated after ~120 nucleotides, forming stable R-loops. These nascent R-loops cannot directly prime mtDNA synthesis, but must first be processed by RNase H1 to generate 3′-ends that can be used by DNA polymerase γ to initiate DNA synthesis. Our findings are consistent with recent studies of a knockout mouse model, which demonstrated that RNase H1 is required for R-loop processing and mtDNA maintenance in vivo. Both R-loop formation and DNA replication initiation are stimulated by the mitochondrial single-stranded DNA binding protein. In an RNase H1 deficient patient cell line, the precise initiation of mtDNA replication is lost and DNA synthesis is initiated from multiple sites throughout the mitochondrial control region. In combination with previously published in vivo data, the findings presented here suggest a model, in which R-loop processing by RNase H1 directs origin-specific initiation of DNA replication in human mitochondria. Human mitochondria contain a double-stranded DNA genome that codes for key components of the oxidative phosphorylation system. The mitochondrial DNA (mtDNA) is replicated by a replication machinery distinct from that operating in the nucleus and mutations affecting individual replication factors have been associated with an array of rare, human diseases. In the present work, we demonstrate that RNase H1 directs origin-specific initiation of DNA replication in human mitochondria and that disease-causing mutations may impair this process. A unique feature of mtDNA replication is that primers required for initiation of leading-strand DNA replication are produced by the mitochondrial transcription machinery. A substantial fraction of all transcription events is prematurely terminated about 120 nucleotides downstream of the promoter and the RNA remains firmly associated with the genome, forming R-loops. Interestingly, the free 3′-end of these R-loops cannot directly prime initiation of DNA synthesis, but must first be processed by RNase H1. The process is stimulated by the mitochondrial single-stranded DNA binding protein and faithfully reconstitutes replication events mapped in vivo. In combination with mapping of replication events in fibroblasts derived from patients with mutations in RNASEH1, our findings point to a possible model for replication initiation in human mitochondria similar to that previously described in the E. coli plasmid, ColE1.

7 March 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
TCThomas M. Connor
Thomas M. Connor
SHSimon Hoer
Simon Hoer
Andrew MallettAndrew Mallett
Andrew Mallett
DGDaniel P. Gale
Daniel P. Gale
AGAurora Gomez-Duran
Aurora Gomez-Duran
PMPatrick H. Maxwell
Patrick H. Maxwell
Tubulointerstitial kidney disease is an important cause of progressive renal failure whose aetiology is incompletely understood. We analysed a large pedigree with maternally inherited tubulointerstitial kidney disease and identified a homoplasmic substitution in the control region of the mitochondrial genome (m.547A>T). While mutations in mtDNA coding sequence are a well recognised cause of disease affecting multiple organs, mutations in the control region have never been shown to cause disease. Strikingly, our patients did not have classical features of mitochondrial disease. Patient fibroblasts showed reduced levels of mitochondrial tRNAPhe, tRNALeu1 and reduced mitochondrial protein translation and respiration. Mitochondrial transfer demonstrated mitochondrial transmission of the defect and in vitro assays showed reduced activity of the heavy strand promoter. We also identified further kindreds with the same phenotype carrying a homoplasmic mutation in mitochondrial tRNAPhe (m.616T>C). Thus mutations in mitochondrial DNA can cause maternally inherited renal disease, likely mediated through reduced function of mitochondrial tRNAPhe. Mitochondria provide the cell’s energy through respiration, using glucose and oxygen to produce ATP. Critical components for this process are encoded by maternally inherited mitochondrial DNA. Mutations in mitochondrial DNA usually affect organs that use energy intensively, notably the brain, eyes and muscles. Here we have discovered a variant in the promoter region of mitochondrial DNA in a large family with kidney disease and normal function in other organs. We show that patient-derived mitochondria do not generate energy normally and have reduced promoter activity, leading to loss of mitochondrial gene expression. We also identify similar mutations that might provide a mechanism for other cases of unexplained inherited kidney disease: two families with reduced cellular respiration carry mutations affecting mitochondrial phenylalanine tRNA, normally required for mitochondrial protein translation. Together, this study provides the first example of a disease-causing mutation in the mitochondrial promoter, and also establishes that the kidney is particularly sensitive to different mutations in mitochondrial DNA. As these can arise from a mutation in the promoter region of mitochondrial DNA or in the tRNA itself, and both reduce the amount of mitochondrial phenylalanine tRNA, this may provide a potential unifying mechanism for mitochondrially inherited kidney disease.